Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children.
Elena Lionetti, Dorina Pjetraj, Simona Gatti...
https://pubmed.ncbi.nlm.nih.gov/36682923/Actively Recruiting
Led by Istituto Giannina Gaslini · Updated on 2026-05-04
60
Participants Needed
1
Research Sites
26 weeks
Total Duration
Researchers are studying children and adolescents with newly diagnosed celiac disease who also have iron deficiency or anemia caused by poor iron absorption and chronic inflammation. The goal is to see if adding Sucrosomial iron supplements to a gluten-free diet helps restore iron levels and hemoglobin faster than following the diet alone. This randomized, double-blind, placebo-controlled study focuses on school-age children with low iron stores or iron deficiency anemia. Participants will receive either oral Sucrosomial iron drops or placebo drops along with their gluten-free diet for 6 months. Dosage varies by age and development stage, with different amounts given to those with hypoferritinemia compared to those with anemia. The study includes two groups one with low iron stores and one with anemia, each randomized to active or placebo treatment. During the 6-month treatment, researchers will measure the time it takes for iron levels to normalize, changes in hemoglobin, iron markers, vitamin B12, folate, and fatigue scores. They will also assess quality of life, adherence to the gluten-free diet, gastrointestinal symptoms, and monitor for any treatment-related side effects. Total participation lasts about 6 months from enrollment to the end of treatment.
CONDITIONS
Efficacy of Oral Sucrosomial Iron Supplementation in Children With Celiac Disease and Iron Deficiency or Anemia
M
Marco Crocco, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istituto Giannina Gaslini
Lead Sponsor
Pharmanutra S.p.a.
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive oral Sucrosomial iron supplementation or placebo drops in addition to a gluten-free diet to treat iron deficiency or anemia.
Regular visits during the 6-month treatment period
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Elena Lionetti, Dorina Pjetraj, Simona Gatti...
https://pubmed.ncbi.nlm.nih.gov/36682923/James W Varni, Cristiane B Bendo, Jolanda Denham...
https://pubmed.ncbi.nlm.nih.gov/24806837/Srihari Mahadev, Monika Laszkowska, Johan Sundström...
https://pubmed.ncbi.nlm.nih.gov/29689265/G R Corazza, V Villanacci
https://pubmed.ncbi.nlm.nih.gov/15917404/Thomas G DeLoughery
https://pubmed.ncbi.nlm.nih.gov/25271605/James A King, Jocelyn Jeong, Fox E Underwood...
https://pubmed.ncbi.nlm.nih.gov/32022718/B Annibale, C Severi, A Chistolini...
https://pubmed.ncbi.nlm.nih.gov/11197242/Francesca Parisi, Cristiana Berti, Chiara Mandò...
https://pubmed.ncbi.nlm.nih.gov/27588568/G Oberhuber, G Granditsch, H Vogelsang
https://pubmed.ncbi.nlm.nih.gov/10524652/J W Varni, M Seid, P S Kurtin
https://pubmed.ncbi.nlm.nih.gov/11468499/Istituto Giannina Gaslini
Lead Sponsor
Pharmanutra S.p.a.
Collaborating Sponsor